ES8303915A1 - "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina". - Google Patents

"procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".

Info

Publication number
ES8303915A1
ES8303915A1 ES512748A ES512748A ES8303915A1 ES 8303915 A1 ES8303915 A1 ES 8303915A1 ES 512748 A ES512748 A ES 512748A ES 512748 A ES512748 A ES 512748A ES 8303915 A1 ES8303915 A1 ES 8303915A1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
phosphonomicin
tablet form
phosphomicine
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512748A
Other languages
English (en)
Other versions
ES512748A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crinos Industria Farmacobiologica SpA
Original Assignee
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmacobiologica SpA filed Critical Crinos Industria Farmacobiologica SpA
Publication of ES512748A0 publication Critical patent/ES512748A0/es
Publication of ES8303915A1 publication Critical patent/ES8303915A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPRIMIDOS A BASE DE FOSFOMICINA, QUE TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIBIOTICA. CONSISTE EN GRANULAR EN HUMEDO, CON DISOLUCION ACUOSA EDULCORANTE, FOSFOMICINA, EN FORMA DE SU SAL CALCICA, EN PROPORCION ADECUADA PARA QUE CADA COMPRIMIDO CONTENGA 0,25 A 1 G DE FOSFOMICINA; SECADO DEL GRANULADO OBTENIDO Y COMPRENSION AL TAMAÑO DESEADO DE PASTILLAS SIGUIENDO METODOS CONVENCIONALES, PREVIA INCORPORACION DE EXCIPIENTES Y LUBRICANTES USUALES.
ES512748A 1981-06-04 1982-06-01 "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina". Expired ES8303915A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22133/81A IT1136652B (it) 1981-06-04 1981-06-04 Compesizione farmaceutica di fosfomicina in compresse da succhiare

Publications (2)

Publication Number Publication Date
ES512748A0 ES512748A0 (es) 1983-03-01
ES8303915A1 true ES8303915A1 (es) 1983-03-01

Family

ID=11191978

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512748A Expired ES8303915A1 (es) 1981-06-04 1982-06-01 "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".

Country Status (8)

Country Link
EP (1) EP0067136B1 (es)
JP (1) JPS5813509A (es)
AT (1) ATE15139T1 (es)
BE (1) BE893312A (es)
DE (1) DE3265827D1 (es)
ES (1) ES8303915A1 (es)
FR (1) FR2507084B1 (es)
IT (1) IT1136652B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05837A (ja) * 1991-06-20 1993-01-08 Mitsuo Toyoizumi 発泡スチロールによるコンクリート用人工骨材、及びその製造方法
CN100339084C (zh) * 2005-10-09 2007-09-26 王万玉 磷霉素钙分散片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL162079C (nl) * 1967-10-30 1980-04-15 Merck & Co Inc Werkwijze voor het bereiden van (cis-1,2-epoxypropaan) fosfonzuurverbindingen; werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1124610B (it) * 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato

Also Published As

Publication number Publication date
ATE15139T1 (de) 1985-09-15
EP0067136A1 (en) 1982-12-15
IT8122133A0 (it) 1981-06-04
ES512748A0 (es) 1983-03-01
EP0067136B1 (en) 1985-08-28
BE893312A (fr) 1982-09-16
FR2507084A1 (fr) 1982-12-10
FR2507084B1 (fr) 1986-01-31
IT1136652B (it) 1986-09-03
JPH0564126B2 (es) 1993-09-14
JPS5813509A (ja) 1983-01-26
DE3265827D1 (en) 1985-10-03

Similar Documents

Publication Publication Date Title
MY100721A (en) Therapeutic agent.
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
NO2000010I1 (no) Farmasøytisk akseptable salter av esomeprazol
NO912001L (no) Buccal tablett med hurtig utlevering.
ATE99927T1 (de) Pharmazeutische formulierungen.
MY102459A (en) Oral sustained release pharmaceutical preparation.
ATE427103T1 (de) Orale verabreichung von adenosin analogen
PT90466A (pt) Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
ATE73656T1 (de) Entzuendungshemmendes ibuprofen enthaltendes arzneimittel, das in waessriger loesung keinen bitteren geschmack, keine reizung des kehlkopfes und keine intestinale toxizitaet aufweist.
ATE97572T1 (de) Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe.
PH27446A (en) Compound with gastric acid inhibitory effect
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
ES8303915A1 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
GB1327560A (en) Effervescent pharmaceutical preparations
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
GB1357813A (en) Effervescent composition for the treatment of heart diseases
EP0367509A3 (en) Formulations
MY102368A (en) Solid sustained-release composition
GB1454390A (en) Nasal decongestants

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303